Latest Trading on NASDAQ

$60.49
2.21%
(-1.37)
Open 62.44
Previous Close 61.86
Today's Range
60.25 62.44
52 Week Range
59.55 90.19
Volume 683.20K
Avg. Volume (Weekly) 462.18K
Bid 47.36
Ask 63.75
Market Cap 3.75M
EPS -7.38
Shares Outstanding 60.70K
YTD High 85.00
Updated October 13, 2020

Arena Pharmaceuticals Inc.

Arena Pharmaceuticals Inc. (“Arena”) develops drugs that selectively target protein receptors of cells. Its research and development efforts are premised under the hypothesis that drugs designed to selectively target these receptors provide more effective and safe treatments.

ARNA Options Prices

Calls (Expiration: 08/06/2021)
Contract Name Strike Last Bid Ask Change %Chg Volume Open Int
ARNA210820C00035000 35.00 0.00 23.20 28.00 unch unch 0 0
ARNA210820C00040000 40.00 20.90 18.60 22.60 -2.86 -12.04% 5 5
ARNA210820C00045000 45.00 0.00 13.40 17.10 unch unch 0 0
ARNA210820C00050000 50.00 0.00 8.20 13.00 unch unch 0 0
ARNA210820C00055000 55.00 6.27 5.00 7.40 -7.18 -53.38% 2 5
ARNA210820C00060000 60.00 2.88 0.80 4.30 -2.57 -47.16% 2 27
ARNA210820C00065000 65.00 1.70 0.25 2.40 -0.90 -34.62% 1 584
ARNA210820C00070000 70.00 1.05 0.10 0.90 unch unch 24 346
ARNA210820C00075000 75.00 0.57 0.15 0.30 -0.08 -12.31% 10 99
ARNA210820C00080000 80.00 0.90 0.05 0.75 0.57 172.73% 2 195
ARNA210820C00085000 85.00 0.30 0.10 4.80 -0.05 -14.29% 1 25
ARNA210820C00090000 90.00 0.22 0.10 4.80 -0.41 -65.08% 1 26
ARNA210820C00095000 95.00 0.00 0.05 4.80 unch unch 0 0
ARNA210820C00100000 100.00 0.23 0.05 5.00 -0.22 -48.89% 3 4
ARNA210820C00105000 105.00 0.00 0.05 4.80 unch unch 0 0
Puts (Expiration: 08/06/2021)
Symbol Strike Last Bid Ask Change %Chg Volume Open Int
ARNA210820C00035000 35.00 0.00 23.20 28.00 unch unch 0 0
ARNA210820C00040000 40.00 20.90 18.60 22.60 -2.86 -12.04% 5 5
ARNA210820C00045000 45.00 0.00 13.40 17.10 unch unch 0 0
ARNA210820C00050000 50.00 0.00 8.20 13.00 unch unch 0 0
ARNA210820C00055000 55.00 6.27 5.00 7.40 -7.18 -53.38% 2 5
ARNA210820C00060000 60.00 2.88 0.80 4.30 -2.57 -47.16% 2 27
ARNA210820C00065000 65.00 1.70 0.25 2.40 -0.90 -34.62% 1 584
ARNA210820C00070000 70.00 1.05 0.10 0.90 unch unch 24 346
ARNA210820C00075000 75.00 0.57 0.15 0.30 -0.08 -12.31% 10 99
ARNA210820C00080000 80.00 0.90 0.05 0.75 0.57 172.73% 2 195
ARNA210820C00085000 85.00 0.30 0.10 4.80 -0.05 -14.29% 1 25
ARNA210820C00090000 90.00 0.22 0.10 4.80 -0.41 -65.08% 1 26
ARNA210820C00095000 95.00 0.00 0.05 4.80 unch unch 0 0
ARNA210820C00100000 100.00 0.23 0.05 5.00 -0.22 -48.89% 3 4
ARNA210820C00105000 105.00 0.00 0.05 4.80 unch unch 0 0
Show more

Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs. BELVIQ (lorcaserin HCl), their internally discovered drug for chronic weight management, is their first and only drug approved by any regulatory agency for marketing. BELVIQ was approved by the US Food and Drug Administration, or FDA, for marketing in the United States, and was made available by prescription in June 2013 to adults who are overweight with a comorbidity or obese. They are exploring BELVIQ for possible new indications, using different formulations, and in combination with other drugs.